Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

BACKGROUND: In a Dutch phase II trial conducted between 2006 and 2010, short-course radiotherapy followed by systemic therapy with capecitabine, oxaliplatin, and bevacizumab as neoadjuvant treatment and subsequent radical surgical treatment of primary tumor and metastatic sites was evaluated. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisschop, C., van Dijk, T. H., Beukema, J. C., Jansen, R. L. H., Gelderblom, H., de Jong, K. P., Rutten, H. J. T., van de Velde, C. J. H., Wiggers, T., Havenga, K., Hospers, G. A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539276/
https://www.ncbi.nlm.nih.gov/pubmed/28560600
http://dx.doi.org/10.1245/s10434-017-5897-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539276/
https://www.ncbi.nlm.nih.gov/pubmed/28560600
http://dx.doi.org/10.1245/s10434-017-5897-0

Ejemplares similares